Latest Breaking News On - China national reimbursement drug list - Page 1 : comparemela.com

HUTCHMED Highlights Publication of Phase III FRUTIGA Results in Nature Medicine

Updated subgroup efficacy and quality of life data were also presented on June 1 at ASCO 2024HONG KONG and SHANGHAI and FLORHAM PARK, N.J., June 03, 2024 HUTCHMED Limited today announces that.

Hong kongUnited statesFreddy crossleyDaphne zhangEli lillyBen atwell alex shawAtholl tweedieZhou yiStock exchange of hong kongChina national reimbursement drug listChina limitedWorld health organizationAmerican society of clinical oncologyJournal of the american medical associationExchange commissionAmerican society

HUTCHMED Initiates Phase II/III Trial of the Combination of Surufatinib and Camrelizumab for Treatment-Naïve Pancreatic Ductal Adenocarcinoma in Collaboration with Hengrui

HUTCHMED Initiates Phase II/III Trial of the Combination of Surufatinib and Camrelizumab for Treatment-Naïve Pancreatic Ductal Adenocarcinoma in Collaboration with Hengrui
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Hong kongBen atwell alex shawHengrui pharmaZhou yiWeiguo suAtholl tweedieChina national reimbursement drug listDrug administrationStock exchange of hong kongExchange commissionChina limitedJiangsu hengrui pharmaceuticals co ltd pharmaChief executive officerChief scientific officerCancers symposiumOrphan drug designation

HUTCHMED Initiates Phase II/III Trial with Hengrui | Company Announcement

HUTCHMED Initiates Phase II/III Trial with Hengrui | Company Announcement
investegate.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investegate.co.uk Daily Mail and Mail on Sunday newspapers.

Hong kongWeiguo suBen atwell alex shawZhou yiAtholl tweedieHengrui pharmaDrug administrationStock exchange of hong kongChina national reimbursement drug listJiangsu hengrui pharmaceuticals co ltd pharmaChina limitedExchange commissionPancreatic ductal adenocarcinomaFlorham parkChief executive officerChief scientific officer

Zai Lab Announces First Quarter 2024 Financial Results and Recent Corporate Updates

Zai Lab Announces First Quarter 2024 Financial Results and Recent Corporate Updates
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United statesHong kongAndrew zhuBristol myers squibbEfgartigimod fcrnXanomeline trospium karSimcere zaimingJosh smileyZai lab limitedChina national reimbursement drug listExchange commissionPfizer incSchizophrenia international research societyNational medical products administrationZai lab forwardDrug administration

HUTCHMED Announces Positive CHMP Opinion for Fruquintinib in Previously Treated Metastatic Colorectal Cancer Received by Takeda

HUTCHMED Announces Positive CHMP Opinion for Fruquintinib in Previously Treated Metastatic Colorectal Cancer Received by Takeda
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United statesHong kongAl qahirahWeiguo suAhcene djaballahDaphne zhangFreddy crossleyAtholl tweedieGastroenterol hepatolZhou yiAwny farajallahEli lillyBen atwell alex shawChina national reimbursement drug listAmerican cancer societyChina limited